Can a smartphone app help smokers quit for good?

This trial tests whether a digital medical device called Quitoxil®, which offers cognitive behavioral therapy and connects users with trained patient experts, can improve smoking cessation rates when added to standard nicotine replacement therapy. About 600 adults who smoke at least 5 cigarettes daily and want to quit will be randomly assigned to receive either standard care alone or standard care plus the Quitoxil® program. The main question is whether more people in the Quitoxil® group can stay smoke-free for at least 7 consecutive days after 6 months, confirmed by a breath test.